Towards a healthier you with

Adult Vaccination Subsidies

Who is eligible?

All Singapore Citizens who meet criteria for vaccination under the National Adult Immunisation Schedule (NAIS) are eligible for subsidies for nationally-recommended vaccinations.

What are the benefits?

Singaporeans will benefit from higher subsidies of between $35 to $125 for nationally-recommended vaccinations listed on the Subsidised Vaccine List (SVL) administered at CHAS GP clinics.  Eligible Singaporeans need only pay the following amounts for the range of nationally recommended vaccinations at our clinic, after government subsidies:

Subsidized Rates

S/N Vaccine Pioneer Generation (PG) Merdeka Generation (MG)/ CHAS Blue/Orange CHAS Green / Non-CHAS
1 Influenza (INF) (trivalent or quadrivalent) $9 $18 $35
2 Pneumococcal conjugate (PCV13) $16 $31 $63
3 Pneumococcal polysaccharide (PPSV23) $11 $22 $43
4 Tetanus, reduced diphtheria and acellular pertussis (Tdap) $10 $20 $40
5 Human papillomavirus (HPV2 or HPV4) N.A. $23 $45
6 Hepatitis B (HepB) $9 $19 $38
7 Measles, mumps and rubella (MMR) $9 $18 $35
8 Varicella (VAR) for Chickenpox $11 $23 $45

Ministry of Health’s Health Appointment System

Bethesda Medical is part of the Ministry of Health and Health Promotion Board’s Health Appointment System (HAS)

The HAS was setup by Open Government Products (OGP), a division in GovTech Singapore, to make it easier for individuals, especially the elderly, to receive their vaccine. HAS directly connects patients to CHAS GP clinics (Community Health Assist Scheme General Practitioner clinics), to simplify and accelerate the vaccination process. Bethesda Medical is proud to be a part of this programme to provide subsidised vaccination for eligible citizens and to reduce their waiting time at the clinic through the system.

How to book?

You may book through Health Appointment System (HAS) by visiting, simply search for ‘Bethesda Medical’, or book through our appointment page here and select a slot at your convenience.

MediSave500 or MediSave700 Scheme

From 1 Jan 2021, patients with complex chronic conditions will be able to use up to $700 per patient yearly, while other patients will be able to use up to $500 per patient yearly for the following treatments.

Outpatient treatments of the following 23 conditions under the Chronic Disease Management Programme (CDMP) (subject to 15% co-payment by patient):
Diabetes, hypertension, lipid disorders, stroke, asthma, chronic obstructive pulmonary disease (COPD), schizophrenia, major depression, bipolar disorders, dementia, osteoarthritis, anxiety, benign prostatic hyperplasia, Parkinson’s disease, nephrosis/nephritis , epilepsy, osteoporosis, psoriasis, rheumatoid arthritis, ischaemic heart disease, allergic rhinitis, gout, chronic hepatitis B.

Adult Vaccinations (for target populations under the National Adult Immunisation Schedule)

1. Influenza*
2. Pneumococcal vaccinations*
3. Human Papillomavirus (HPV) (for females between 9 and 26 years of age)
i) Cervarix
ii) Gardasil (4-valent HPV vaccine)
4. Hepatitis B vaccination
5. Measles, Mumps and Rubella (MMR)
6. Diphtheria, Pertussis & Tetanus (DTaP/Tdap)
7. Varicella (Chickenpox)

* Also recommended for specific groups of children, including those with medical conditions or immunocompromised or with rare conditions.

Recommended vaccinations differ for different target population groups. Medisave limits apply.
Please consult with our doctor to find out which vaccinations are recommended, and if you are suitable for the vaccination(s)

Fully Subsidised Vaccines under National Adult Immunisation Schedule (NAIS)

The National Adult Immunisation Schedule (NAIS) was established in November 2017 to provide guidance on vaccinations that persons age 18 years or older should adopt to protect themselves against vaccine-preventable diseases.

Certain adults are at increased risk of complications or susceptible to vaccine preventable diseases if they have not previously received the vaccination and are in contact with individuals who have the infection. Vaccinations recommended under the NAIS aim to prevent such infections among susceptible individuals and reduce complications, morbidity and mortality.

The NAIS was developed based on international best practice and the recommendations of the Expert Committee on Immunisation (ECI). Considerations include: 

  • local disease burden;
  • age, occupation, pre-existing medical conditions, vaccination history; 
  • vaccine safety, efficacy and cost effectiveness of the vaccines in preventing infections among susceptible individuals and reducing complications, morbidity and mortality.

The vaccines in the NAIS protect against the following 11 diseases – Influenza, pneumococcal disease, human papillomavirus, tetanus, diphtheria, pertussis, measles, mumps, hepatitis B, and varicella (chickenpox).

Singapore Citizens who are enrolled in Healthier SG are able to have fully subsidised Vaccinations that are under NAIS.
CHAS and Medisave can also be used to subsidise the cost of vaccines.


Enquiries about Adult Vaccination Subsidies?